Loading
Archives of Clinical and Experimental Ophthalmology
ISSN: 2692-4331
Ocular surface disease management in cataract surgery
According to the literature, 80% of patients undergoing cataract surgery suffer from ocular surface disease (OSD). Along with postoperative refractive surprise, the onset of OSD is the main cause of dissatisfaction in cataract surgery patients, accounting for 35% of cases. These patients are characterized by persistent dysregulation of ocular surface para-inflammation, leading to chronic low- grade inflammation with significant consequences on daily activities and work productivity. This study aims to investigate the effects of topical desonide sodium phosphate 0.025% eye drops on the signs and symptoms of OSD in patients undergoing cataract surgery.
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p1-7 | DOI: 10.46439/ophthalmology.7.035
Comment on “Use of refractive aids among adults in a general population”
This commentary is a further discussion of results from the FORSYN study recently published in Scientific Reports [1]. In the FORSYN study 10,350 people selected by Statistics Denmark to represent the adult Danish population with respect to age, sex, and socio-economical parameters were invited for a non-cycloplegic examination at the Department of Ophthalmology, Aarhus University Hospital.
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p8-9 | DOI: 10.46439/ophthalmology.7.036
Considerations regarding the visual and social limitations of children with congenital Zika syndrome
Congenital Zika syndrome (CZS) results from maternal exposure to the Zika virus during pregnancy. A large number of newborns were affected during the Zika virus outbreak occurred insome Northeast regions of Brazil during the years 2015 and 2016 .
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p10-11 | DOI: 10.46439/ophthalmology.7.037
Commentary on analysis of contrastsensitivity in patients implanted with AcunexVario and LuxSmart extended depth of focus (E-DOF) intraocular lenses (IOLs)
The significance of contrast sensitivity (CS) in impacting real visual ability cannot be emphasized enough. In recent years, cataract surgeons and ophthalmologists globally have been focusing more on it. Visual acuity is no longer the sole measure of vision quality, especially in low-light conditions.
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p12-16 | DOI: 10.46439/ophthalmology.7.038
Long-term success in phacoemulsification surgery: what can we learn?
Phacoemulsification has become the gold standard in cataract surgery due to its effectiveness and rapid visual recovery. Understanding the long-term factors influencing surgical success is critical, particularly in resource-limited settings.
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p17-20 | DOI: 10.46439/ophthalmology.7.039
Non-human primate models and multimodal technologies synergistically drive translational breakthroughs in gene therapy for optic nerve diseases
This commentary systematically examines the pivotal role of non-human primate (NHP) models in advancing gene therapy for optic nerve diseases, alongside the ethical and practical challenges they face. It highlights how synergistic innovations in artificial intelligence (AI), organoid technology, CRISPR-based gene editing, and novel delivery systems are reshaping translational paradigms.
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p21-24 | DOI: 10.46439/ophthalmology.7.040
Complement C5 inhibition in acute AQP4-IgG NMOSD attacks: A review of the rationale and clinical evidence
Neuromyelitis optica spectrum disorder (NMOSD) with aquaporin-4 immunoglobulin G positivity (AQP4-IgG) is a severe autoimmune disease of the central nervous system (CNS) characterized by inflammatory attacks targeting the optic nerves and spinal cord. Pathologically, these attacks are driven by the binding of pathogenic AQP4-IgG to astrocytes, which triggers a potent, complement-dependent cytotoxicity.
Arch Clin Exp Ophthalmol, 2025, Volume 7, Issue 1, p25-29 | DOI: 10.46439/ophthalmology.7.041